Patents-Review.com
🔗 Permalink
Assignee profile:

UMECRINE AB

City:

Umea

Country:

Sweden

Published Applications:

11

Last publication date:

2024-11-21

Patent Grants:

6

Last grant date:

2014-10-07

Top Inventors for applications by UMECRINE AB

These are the the leading inventors for applications assigned to UMECRINE AB:

Recent patent applications by UMECRINE AB

UMECRINE AB based in Umea, SE has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2024-11-21
US20240383941A1
Chemistry; metallurgy

3-ALPHA SUBSTITUTED 3-BETA-HYDROXY-17-OXIMATED ANDROSTANE COMPOUND FOR MODULATION OF THE ALPHA-3 SUBTYPE OF THE GABAA RECEPTOR

 #2 | 2014-01-09
US20140011793A1
Chemistry; metallurgy

NEW STEROIDS HAVING INCREASED WATER SOLUBILITY AND RESISTANCE AGAINST METABOLISM, AND METHODS FOR THEIR PRODUCTION

 #3 | 2014-01-09
US20140011792A1
Chemistry; metallurgy

STEROIDS HAVING INCREASED WATER SOLUBILITY AND RESISTANCE AGAINST METABOLISM AND METHODS FOR THEIR PRODUCTION

 #4 | 2014-01-09 ✅ Patent 8,853,190 granted on 2014-10-07
US20140011779A1
Chemistry; metallurgy

Steroids having increased water solubility and resistance against metabolism, and methods for their production

 #5 | 2013-04-25
US20130102579A1
Chemistry; metallurgy

Steroids Having Increased Water Solubility and Resistance Against Metabolism and Methods For Their Production

 #6 | 2013-04-25
US20130102578A1
Chemistry; metallurgy

New Steroids Having Increased Water Solubility and Resistance Against Metabolism and Methods For Their Production

 #7 | 2012-06-07 ✅ Patent 8,372,824 granted on 2013-02-12
US20120142657A1
Human necessities

GABA-steroid antagonists and their use for the treatment of CNS disorders

 #8 | 2011-04-28 ✅ Patent 8,119,619 granted on 2012-02-21
US20110098259A1
Human necessities

Pregnane steroids and their use in the treatment of CNS disorders

 #9 | 2008-05-22 ✅ Patent 8,580,983 granted on 2013-11-12
US20080119416A1
Chemistry; metallurgy

Steroids having increased water solubility and resistance against metabolism, and methods for their production

 #10 | 2008-03-20 ✅ Patent 8,114,860 granted on 2012-02-14
US20080070876A1
Human necessities

GABA-steroid antagonists and their use for the treatment of CNS disorders

 #11 | 2005-10-06 ✅ Patent 7,888,340 granted on 2011-02-15
US20050222099A1
Human necessities

Pregnane steroids and their use in the treatment of CNS disorders

Also check out Umecrine AB's (Umeå, Sweden) applicant profile with 2 patent applications submitted.

AssigneeID:

19687 ⎘